Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts
- PMID: 16087157
- DOI: 10.1016/j.bbrc.2005.07.127
Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts
Abstract
Thrombopoietin (TPO) is the growth factor for megakaryocytes and platelets, however, it also acts as a potent regulator of stem cell proliferation. To examine the significance of TPO expression in proliferation of hepatic oval cells, the effect of adenovirus-mediated TPO gene transfer into livers of the Solt-Farber model, which mimics the condition where liver regeneration is impaired, was examined. Hepatic TPO mRNA peaked its expression at 2 days after gene transduction and then gradually decreased. The peripheral platelet number began to increase at 4 days (P<0.05) and reached its plateau at 9 days (P<0.01). Oval cells expressed c-Mpl, a receptor for TPO as well as immature hematopoietic and hepatocytic surface markers such as CD34 and AFP. The proliferating cell nuclear antigen-positive oval cells in rats into which adenovirus-TPO gene was transferred at 7 and 9 days were significantly greater than those in adenovirus-LacZ gene transferred (P<0.05, each), and the total numbers of oval cells in the adenovirus-TPO gene transferred at 9 and 13 days were also significantly greater than those in adenovirus-LacZ gene transferred (P<0.05, each). Expression of SCF protein was increased at 4, 7, and 9 days by TPO gene administration and that of c-Kit was increased at 4 and 7 days. These data suggest that adenovirus-mediated TPO gene transfer stimulated oval cell proliferation in liver as well as increasing peripheral platelet counts, emphasizing the significance of the TPO/c-Mpl system in proliferation of hepatic oval cells.
Similar articles
-
Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat.Lab Invest. 1994 Apr;70(4):511-6. Lab Invest. 1994. PMID: 7513770
-
Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats.Hepatogastroenterology. 2005 Sep-Oct;52(65):1393-7. Hepatogastroenterology. 2005. PMID: 16201081
-
Thrombopoietin is a growth factor for rat hepatic progenitors.Eur J Gastroenterol Hepatol. 2008 Mar;20(3):209-16. doi: 10.1097/MEG.0b013e3282f246e6. Eur J Gastroenterol Hepatol. 2008. PMID: 18301302
-
Thrombopoietin: its role from early hematopoiesis to platelet production.Haematologica. 1999 Feb;84(2):158-66. Haematologica. 1999. PMID: 10091415 Review.
-
Thrombopoietin regulates differentiation of rhesus monkey embryonic stem cells to hematopoietic cells.Ann N Y Acad Sci. 2005 Jun;1044:29-40. doi: 10.1196/annals.1349.005. Ann N Y Acad Sci. 2005. PMID: 15958695 Review.
Cited by
-
Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.World J Gastroenterol. 2010 Aug 28;16(32):4019-30. doi: 10.3748/wjg.v16.i32.4019. World J Gastroenterol. 2010. PMID: 20731015 Free PMC article. Review.
-
Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.Int J Clin Exp Pathol. 2013 Aug 15;6(9):1759-69. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24040440 Free PMC article.
-
Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.PLoS One. 2015 Jan 22;10(1):e0116985. doi: 10.1371/journal.pone.0116985. eCollection 2015. PLoS One. 2015. PMID: 25611592 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases